Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis
- 1 February 1994
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 75 (1) , 58-60
- https://doi.org/10.1016/0962-8479(94)90104-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Hepatotoxicity of Rifampin and Isoniazid: Is It All Drug-induced Hepatitis?American Review of Respiratory Disease, 1991
- Prevalence of antibodies to hepatitis C virus in blood donors and risk groups in Istanbul, TurkeyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Toxic Hepatitis with Isoniazid and RifampinChest, 1991
- Hepatic toxicity in south indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamideTubercle, 1986
- Drug-Induced HepatotoxicityAnnals of Internal Medicine, 1986
- Short-Course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampinThe American Journal of Medicine, 1984